Cerus Corp (NASDAQ:CERS)

CAPS Rating: 3 out of 5

The Company develops and commercializes novel, proprietary products and technologies within the fields of blood safety and immunotherapy that provides safer and more medical options to patients in areas of unmet medical need.

Caps

How do you think CERS will perform against the market?

Add Stock to CAPS Watchlist

All Players

140 Outperform
14 Underperform
 

All-Star Players

17 Outperform
6 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top CERS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

flstfi88 (22.03)
Submitted April 26, 2010

The Intercept system will be approved by the FDA for the US and this will become very profitable.

zzlangerhans (99.83)
Submitted November 29, 2015

The biotech sector rebound is lifting up a lot of stocks that have been unfairly beaten down, and some others like Cerus whose weakness was more deserved. Revenues have been stagnant this year, which management initially blamed on the Euro and more… More

CERS VS S&P 500 (SPY)

Fools bullish on CERS are also bullish on:

Fools bearish on CERS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CERS.

Recs

0
Member Avatar sk2129 (33.38) Submitted: 11/30/2015 4:37:56 PM : Outperform Start Price: $4.49 CERS Score: -55.77

baker bros.

Recs

0
Member Avatar Saveupnow (< 20) Submitted: 2/13/2014 2:25:47 PM : Outperform Start Price: $7.29 CERS Score: -99.54

FDA approval expected this year, need cleaner blood and plasma

Recs

0
Member Avatar IFindKaching (< 20) Submitted: 4/18/2011 12:38:26 PM : Outperform Start Price: $2.74 CERS Score: -88.54

CERS is the best option in the critical market for blood supply protection. Already accepted in Europe and other parts of the world, it's only a matter of time for FDA approval in the US. When that happens...

Leaderboard

Find the members with the highest scoring picks in CERS.

Score Leader

ahknaten

ahknaten (97.32) Score: +171.22

The Score Leader is the player with the highest score across all their picks in CERS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ericsmu 38.79 10/4/2006 Underperform 3W $5.60 -46.61% +102.97% +149.57 0 Comment
BicaChica 78.43 3/26/2008 Underperform 5Y $5.86 -48.98% +99.10% +148.08 0 Comment
NatedoggGT1 83.86 10/16/2007 4/14/2008 Underperform 3Y $9.71 -69.21% +74.76% +143.96 0 Comment
ahknaten74 93.08 3/24/2008 Underperform NS $4.79 -37.58% +100.01% +137.59 0 Comment
FundamentalGamma < 20 12/10/2007 Underperform NS $6.96 -57.04% +78.06% +135.10 1 Comment
MassProduced 93.05 2/16/2007 Underperform NS $5.52 -45.83% +87.63% +133.47 0 Comment
clover0958 64.15 5/9/2007 Underperform 3M $5.77 -48.18% +80.26% +128.44 0 Comment
mifollower 23.82 1/21/2011 Underperform NS $3.59 -16.71% +99.50% +116.21 0 Comment
dwn88ir 55.48 5/21/2012 Underperform 5Y $3.49 -14.33% +95.76% +110.09 0 Comment
Morgan5588 < 20 5/21/2012 Underperform 5Y $3.37 -11.28% +97.53% +108.81 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCowenandCo 87.84 10/8/2012 Outperform NS $3.44 -13.08% +76.59% -89.67 0 Comment
TrackRWBaird 90.29 2/29/2012 Outperform NS $3.80 -21.32% +86.64% -107.95 0 Comment
TrackMLVCo < 20 11/10/2011 Outperform NS $2.81 +32.74% +10.91% +21.83 4/17/2012 @ $3.73 0 Comment
TrackWedbush 84.84 6/3/2011 Outperform NS $2.88 +3.82% +97.55% -93.73 0 Comment
TrackRWBaird 90.29 3/9/2010 Outperform NS $2.62 +14.50% +17.05% -2.54 3/4/2011 @ $3.00 0 Comment
TrackJMP 84.66 1/29/2008 Outperform NS $6.25 -4.00% +4.16% -8.16 5/2/2008 @ $6.00 0 Comment
TrackMichaelBrus 79.84 3/7/2007 Outperform 1Y $5.75 -48.00% +94.13% -142.13 0 Comment
TrackJMP 84.66 2/23/2007 Outperform NS $5.96 +8.39% +3.18% +5.21 5/2/2007 @ $6.46 0 Comment

Featured Broker Partners